Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement

Mingzhou Li1, Jean G Dumesnil, Patrick Mathieu

  • 1Research Group in Valvular Heart Diseases, Research Center of Laval Hospital/Quebec Heart Institute, Laval University, 2725 Chemin Saint-Foy, Sainte-Foy, Quebec, Canada G1V 4G5.

Abstract

Insights

Prosthesis-patient mismatch (PPM) after mitral valve replacement (MVR) significantly increases pulmonary arterial (PA) pressure. Avoiding PPM through careful valve selection can prevent persistent PA hypertension post-MVR.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomedical Engineering

Background:

  • Pulmonary arterial hypertension (PAH) is a severe complication of mitral valve disease.
  • PAH is a significant risk factor for adverse outcomes following mitral valve replacement (MVR).
  • Prosthesis-patient mismatch (PPM) is hypothesized to contribute to PA hypertension post-MVR.

Purpose of the Study:

  • To investigate the relationship between valve prosthesis-patient mismatch (PPM) and pulmonary arterial (PA) pressure.
  • To assess the impact of PPM on PA pressure after mitral valve replacement (MVR).

Main Methods:

  • Systolic PA pressure was measured using Doppler echocardiography in 56 patients with functioning mitral prosthetic valves.
  • Mitral valve effective orifice area (EOA) was calculated via the continuity equation and indexed to body surface area.
  • PPM was defined as indexed EOA ≤ 1.2 cm²/m².

Main Results:

  • 54% of patients had PA hypertension (systolic PA pressure >40 mm Hg).
  • 71% of patients exhibited PPM.
  • A strong correlation (r=0.64) was observed between systolic PA pressure and indexed EOA.
  • Patients with PPM had significantly higher PA pressure (46±8 mm Hg) and PA hypertension prevalence (68%) compared to those without PPM (34±8 mm Hg, 19%; p<0.001).
  • Indexed EOA was the strongest predictor of systolic PA pressure in multivariate analysis.

Conclusions:

  • Persistent PA hypertension is common after MVR and is strongly linked to PPM.
  • These findings underscore the importance of addressing PPM to improve patient outcomes.
  • Utilizing a prospective strategy during surgery can largely prevent PPM.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...